Form 4 for EXEL EXELIXIS, INC.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0000939767-23-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | 2023-02-15 | EXEL | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | F - Tax | $18.08 | -17.3K | 225.1K | -7% | -$312.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | F | D | 17,299 | $18.08 | 225,088 | D | — | — | (F1) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded January 4, 2022. (F2) Includes 163,817 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |